|
Delayed
NSE India S.E.
06:10:44 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,295.60 INR | -1.52% |
|
-1.31% | +12.78% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
| Market Cap | 658B 6.84B 6.08B 5.67B 5.17B 9.75B 9.85B 68.67B 26.61B 336B 25.69B 25.13B 1,079B | P/E 2027 * |
28.4x | P/E 2028 * | 23.6x |
|---|---|---|---|---|---|
| Enterprise Value | 621B 6.46B 5.74B 5.36B 4.89B 9.21B 9.3B 64.86B 25.13B 318B 24.27B 23.74B 1,019B | EV / Sales 2027 * |
3.7x | EV / Sales 2028 * | 3.26x |
| Free-Float |
51.04% | Yield 2027 * |
0.16% | Yield 2028 * | 0.17% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -1.53% | ||
| 1 week | -1.31% | ||
| Current month | -1.69% | ||
| 1 month | -6.39% | ||
| 3 months | +1.07% | ||
| 6 months | +9.05% | ||
| Current year | +12.78% |
| 1 week | 2,279.3 |  | 2,441.5 |
| 1 month | 2,279.3 | | 2,492 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,792.6 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 86 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.52% | -1.31% | +16.44% | +189.37% | 6.84B | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| -0.95% | -4.05% | +20.54% | +41.71% | 333B | |
| -1.46% | -2.89% | +10.57% | +32.81% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.98% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -0.84% | -3.60% | +25.11% | +71.72% | 370.4B | |
| Weighted average by Cap. | -0.60% | -3.54% | +29.05% | +70.79% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 168B 1.75B 1.55B 1.45B 1.32B 2.49B 2.51B 17.53B 6.79B 85.85B 6.56B 6.42B 276B | 187B 1.95B 1.73B 1.61B 1.47B 2.77B 2.8B 19.53B 7.57B 95.66B 7.31B 7.15B 307B |
| Net income | 23.11B 240M 214M 199M 182M 343M 346M 2.41B 935M 11.81B 903M 883M 37.92B | 27.71B 288M 256M 239M 218M 411M 415M 2.89B 1.12B 14.16B 1.08B 1.06B 45.46B |
| Net Debt | -36.49B -380M -337M -315M -287M -541M -546M -3.81B -1.48B -18.65B -1.43B -1.39B -59.87B | -48B -499M -444M -414M -377M -712M -718M -5.01B -1.94B -24.54B -1.87B -1.83B -78.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | ₹2,295.60 | -1.52% | 137,393 |
| 01/10/26 | ₹2,331.00 | -0.16% | 972,522 |
| 30/09/26 | ₹2,334.70 | -4.37% | 1,261,905 |
| 29/09/26 | ₹2,441.50 | +4.98% | 1,277,155 |
| 28/09/26 | ₹2,325.70 | -2.28% | 985,878 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
